Wakamatsu, T.; Imura, Y.; Tamiya, H.; Yagi, T.; Yasuda, N.; Nakai, S.; Nakai, T.; Outani, H.; Hamada, K.; Kakunaga, S.;
et al. 18F-Fluorodeoxyglucose Positron Emission Tomography Is Useful in the Evaluation of Prognosis in Retroperitoneal Sarcoma. Cancers 2021, 13, 4611.
https://doi.org/10.3390/cancers13184611
AMA Style
Wakamatsu T, Imura Y, Tamiya H, Yagi T, Yasuda N, Nakai S, Nakai T, Outani H, Hamada K, Kakunaga S,
et al. 18F-Fluorodeoxyglucose Positron Emission Tomography Is Useful in the Evaluation of Prognosis in Retroperitoneal Sarcoma. Cancers. 2021; 13(18):4611.
https://doi.org/10.3390/cancers13184611
Chicago/Turabian Style
Wakamatsu, Toru, Yoshinori Imura, Hironari Tamiya, Toshinari Yagi, Naohiro Yasuda, Sho Nakai, Takaaki Nakai, Hidetatsu Outani, Kenichiro Hamada, Shigeki Kakunaga,
and et al. 2021. "18F-Fluorodeoxyglucose Positron Emission Tomography Is Useful in the Evaluation of Prognosis in Retroperitoneal Sarcoma" Cancers 13, no. 18: 4611.
https://doi.org/10.3390/cancers13184611
APA Style
Wakamatsu, T., Imura, Y., Tamiya, H., Yagi, T., Yasuda, N., Nakai, S., Nakai, T., Outani, H., Hamada, K., Kakunaga, S., Araki, N., Ueda, T., & Takenaka, S.
(2021). 18F-Fluorodeoxyglucose Positron Emission Tomography Is Useful in the Evaluation of Prognosis in Retroperitoneal Sarcoma. Cancers, 13(18), 4611.
https://doi.org/10.3390/cancers13184611